MyHealthChecked (MHC) Competitors GBX 9.11 -0.39 (-4.09%) As of 08:16 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock MHC vs. POLX, IHC, AVO, RUA, SUN, MXCT, BELL, DEMG, NIOX, and SNShould you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MaxCyte (MXCT), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), and Smith & Nephew (SN). These companies are all part of the "medical devices" industry. MyHealthChecked vs. Its Competitors Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group MaxCyte Belluscura Deltex Medical Group NIOX Group Smith & Nephew Polarean Imaging (LON:POLX) and MyHealthChecked (LON:MHC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk. Does the media refer more to POLX or MHC? In the previous week, Polarean Imaging's average media sentiment score of 0.00 equaled MyHealthChecked'saverage media sentiment score. Company Overall Sentiment Polarean Imaging Neutral MyHealthChecked Neutral Which has stronger earnings and valuation, POLX or MHC? MyHealthChecked has higher revenue and earnings than Polarean Imaging. MyHealthChecked is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolarean Imaging£5.21M3.35-£69.44M-£3.89-0.31MyHealthChecked£9.43M0.50-£1.04M-£2.00-4.54 Is POLX or MHC more profitable? MyHealthChecked has a net margin of -11.06% compared to Polarean Imaging's net margin of -1,333.97%. MyHealthChecked's return on equity of -12.80% beat Polarean Imaging's return on equity.Company Net Margins Return on Equity Return on Assets Polarean Imaging-1,333.97% -86.11% -32.28% MyHealthChecked -11.06%-12.80%-8.18% Which has more risk & volatility, POLX or MHC? Polarean Imaging has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Comparatively, MyHealthChecked has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Do insiders & institutionals believe in POLX or MHC? 12.1% of Polarean Imaging shares are held by institutional investors. Comparatively, 3.1% of MyHealthChecked shares are held by institutional investors. 39.3% of Polarean Imaging shares are held by insiders. Comparatively, 53.6% of MyHealthChecked shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryMyHealthChecked beats Polarean Imaging on 8 of the 11 factors compared between the two stocks. Get MyHealthChecked News Delivered to You Automatically Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MHC vs. The Competition Export to ExcelMetricMyHealthCheckedMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£4.74M£3.40B£5.52B£3.00BDividend YieldN/A2.44%4.25%5.02%P/E Ratio-4.5475.7628.15169.74Price / Sales0.50101.40438.33285,731.24Price / Cash1.7815.9935.5327.97Price / Book0.633.878.234.61Net Income-£1.04M£132.05M£3.23B£5.90B7 Day Performance-7.22%0.09%-0.01%2.60%1 Month Performance-20.39%10.69%5.61%8.73%1 Year Performance-0.53%14.65%26.52%64.80% MyHealthChecked Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MHCMyHealthCheckedN/AGBX 9.11-4.1%N/A-2.8%£4.74M£9.43M-4.5416Gap DownPOLXPolarean ImagingN/AGBX 1.38-1.6%N/A-22.1%£20.21M£5.21M-0.3528Gap DownIHCInspiration Healthcare GroupN/AGBX 22.01-2.2%N/A+17.4%£19.07M£42.87M-1.51224Gap DownAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 12.35-0.2%N/A+4.5%£7.66M£4.05M-2.8848SUNSurgical Innovations GroupN/AGBX 0.71+1.4%N/A-8.1%£6.62M£12.54M-21.1180MXCTMaxCyteN/AGBX 2.24+3.2%N/A-99.4%£2.96M£57.52M-0.0880High Trading VolumeBELLBelluscuraN/AGBX 0.75flatN/AN/A£1.89M£2.87M-0.0824DEMGDeltex Medical GroupN/AN/AN/AN/A£187K£1.76M-0.1537Gap UpHigh Trading VolumeNIOXNIOX Group2.4124 of 5 starsGBX 68+0.3%GBX 90+32.4%+2.4%£27.93B£3.53B2,806.2492Gap UpSNSmith & Nephew3.8717 of 5 starsGBX 1,107+0.2%GBX 7,840+608.2%+1.7%£12.14B£7.08B39.8618,452News CoverageHigh Trading Volume Related Companies and Tools Related Companies Polarean Imaging Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors MaxCyte Competitors Belluscura Competitors Deltex Medical Group Competitors NIOX Group Competitors Smith & Nephew Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MHC) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredTrump has to finance $21 trillion. Here’s His Move…Trump needs $21 trillion to fund his agenda — and insiders believe he’s quietly preparing a major shift in the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyHealthChecked PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MyHealthChecked With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MHC Stock Alerts